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Summary. Transforming growth factor-l31 (TGF-l31) has 
been shown to modulate both cell proliferation and the 
synthesis of extracellular matrix by vascular cells. This 
study was aimed to establish the temporal correlation 
between TGF-l31 expression, the expression of the 
extracellular matrix protein fibronectin, and plaque 
development during atherogenesis of hyper- 
cholesterolemic rabbits. New Zealand White rabbits 
were fed with 2% cholesterol-supplemented chow for 1 
week, 2 weeks, 3 weeks or 6 weeks. TGF-l31 mRNA and 
protein expression was examined in serial sections of 
aorta by in situ hybridization and immunohisto- 
chemistry. Fibronectin expression was examined by 
immunohistochemistry. In the control and l-week 
feeding group, the expression of TGF-l31 mRNA and 
protein was not apparent. In 2-week feeding group, 
intimal thickening was detected in which TGF-B1 
mRNA and protein were not clearly observed, either. 
The 3-week and 6-week feeding groups exhibited fatty 
streaks in which TGF-l31 mRNA and protein expression 
markedly increased as feeding proceeded. Cell type- 
specific staining indicated that TGF-l31 was expressed 
by macrophages as well as smooth muscle cells of the 
fatty streaks. Immunostaining of fibronectin detected 
low expression levels in control, l-week and 2-week 
feeding groups with pronounced upregulation in the 
thickened intima and the proximal media in 3-week and 
6-week feeding groups. These results implicate a role for 
TGF-l31 in modulating fatty streak formation and the 
synthesis of extracellular protein fibronectin during 
plaque development. 
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Atherosclerosis is a pathophysiological process of 
the vasculature underlying a variety of diseases 
including myocardial and cerebral infarctions. The 
development of atherosclerotic lesions has been shown 
to involve endothelial injury, the recruitment of blood 
monocytes and lymphocytes, the migration and 
proliferation of smooth muscle cells and the interplay 
among these cells through the release of cytokines and 
growth factors (Ross, 1993). The earliest recognizable 
atherosclerotic lesions are fatty streaks whose locations 
are thought to be highly correlated with those of focal 
intimal thickening of the arterial wall (Stary et al., 1992). 
Fatty streaks are characterized by the accumulation of 
lipid droplets in foam cells derived from macrophages 
and smooth muscle cells in both human and animal 
models (Faggiotto et al., 1984; Aqel et al., 1985; Aliev 
and Burnstock, 1998). The activation of macrophages 
and smooth muscle cells plays a pivotal role through the 
development of atherosclerosis. 
Transforming growth factor-B1 (TGF-Bl) is a 
multifunctional cytokine which has been demonstrated 
to modulate the proliferation of a variety of cell types 
and to regulate their interaction with the extracellular 
matrix (Sporn et al., 1986). Experimental evidence 
indicated that TGF-B1 is a potent stimulator for the 
synthesis of proteoglycans (Chen et al., 1987; Schonherr 
et al., 1991) and various extracellular matrix proteins 
(Balza et al., 1988; Lawrence et al., 1994) as well as a 
modulator for proteases associated with extracellular 
matrix proteins (Edwards et al., 1987). In addition to its 
prominent role in regulating extracellular matrix 
formation, TGF-l31 has been previously reported to 
either promote or inhibit growth, depending on cell age, 
cell density, the presence of coexisting factors, and the 
concentration of TGF-l31 (Mii et al., 1993; Halloran et 
al., 1995). TGF-l31 was found to decrease proliferation 
rate of cultured arterial smooth muscle cells by 
extending the G2 phase of cell cycle (Grainger et al., 
1994). On the other hand, expression of active TGF-l31 







